MARINUS PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 3435000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-06-30) |
| Status | current |
| Entity | MARINUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:28.339684+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7a12b3eb-7d39-4db8-93fd-a6cdb60b46ae
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-011982 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:28.339684+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001267813/accounts-receivable/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7a12b3eb-7d39-4db8-93fd-a6cdb60b46ae
History
- no predecessors — first report